Paper21898546
The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.
King TD and 2 others. J Cell Biochem, 2012. Cited by 245 papers, by iCite.
Cite this record
ConductScience Library. The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. Papers, record 21898546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21898546
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Frizzled Receptors | Major topic |
| Low Density Lipoprotein Receptor-Related Protein-6 | Major topic |
| Wnt Signaling Pathway | Major topic |
| Cell Proliferation | |
| Female | |
| Humans | |
| Pyrans | |
| Erb-b2 Receptor Tyrosine Kinases | |
| Receptors, Estrogen | |
| Receptors, Progesterone | |
| Polyether Polyketides |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA124531 | NCI NIH HHS | United States | R01CA124531 | PubMed and NIH |
| R01CA124531 | NCI NIH HHS | United States | R01CA124531 | PubMed and NIH |
Source NIH RePORTER
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17468756 | MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. | Nat Genet | 2007 | https://conductscience.org/library/papers/17468756 | PubMed |
| 2 | 18559090 | The CD44+/CD24- phenotype is enriched in basal-like breast tumors. | Breast Cancer Res | 2008 | https://conductscience.org/library/papers/18559090 | PubMed |
| 3 | 19619488 | Wnt/beta-catenin signaling: components, mechanisms, and diseases. | Dev Cell | 2009 | https://conductscience.org/library/papers/19619488 | PubMed |
| 4 | 12629218 | Prospective identification of tumorigenic breast cancer cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12629218 | PubMed |
| 5 | 20877296 | Triple-negative breast cancer: disease entity or title of convenience? | Nat Rev Clin Oncol | 2010 | https://conductscience.org/library/papers/20877296 | PubMed |
| 6 | 19503830 | The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. | PLoS One | 2009 | https://conductscience.org/library/papers/19503830 | PubMed |
| 7 | 21835542 | Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. | Cancer Lett | 2011 | https://conductscience.org/library/papers/21835542 | PubMed |
| 8 | 14739782 | Wnt signaling and breast cancer. | Cancer Biol Ther | 2004 | https://conductscience.org/library/papers/14739782 | PubMed |
| 9 | 20395444 | Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20395444 | PubMed |
| 10 | 18398311 | Epigenetic gene silencing in the Wnt pathway in breast cancer. | Epigenetics | 2008 | https://conductscience.org/library/papers/18398311 | PubMed |
| 11 | 19473496 | WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. | Breast Cancer Res | 2009 | https://conductscience.org/library/papers/19473496 | PubMed |
| 12 | 16357527 | R-Spondin proteins: a novel link to beta-catenin activation. | Cell Cycle | 2006 | https://conductscience.org/library/papers/16357527 | PubMed |
| 13 | 3180222 | Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. | Cell | 1988 | https://conductscience.org/library/papers/3180222 | PubMed |
| 14 | 20194742 | LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20194742 | PubMed |
| 15 | 16263759 | Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. | J Cell Sci | 2005 | https://conductscience.org/library/papers/16263759 | PubMed |
| 16 | 21727895 | Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. | Nature | 2011 | https://conductscience.org/library/papers/21727895 | PubMed |
| 17 | 21788521 | Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21788521 | PubMed |
| 18 | 18283316 | Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18283316 | PubMed |
| 19 | 19682730 | Identification of selective inhibitors of cancer stem cells by high-throughput screening. | Cell | 2009 | https://conductscience.org/library/papers/19682730 | PubMed |
| 20 | 19672307 | The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. | PLoS One | 2009 | https://conductscience.org/library/papers/19672307 | PubMed |
Cited by173
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 245 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42589239 | The Molecular Structure, Expression, and Emerging Role of the 15-Leucine-Rich Repeat Containing Membrane Protein (LRRC15) in Skeletal Biology and Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589239 | PubMed |
| 42570972 | Escherichia coli DH5α-loaded fenugreek extract: an effective anticancer combination against human breast cancer cell lines. | Appl Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42570972 | PubMed |
| 42100345 | The role of pluripotency regulators in triple-negative breast cancer immune response. | Front Genet | 2026 | https://conductscience.org/library/papers/42100345 | PubMed |
| 41696244 | Loading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates. | ACS Omega | 2026 | https://conductscience.org/library/papers/41696244 | PubMed |
| 41524847 | Wnt ligands in breast cancer metastasis: unraveling their dual roles and therapeutic potential. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41524847 | PubMed |
| 41150754 | Monitoring Pharmacological Treatment of Breast Cancer with MRI. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150754 | PubMed |
| 41069341 | Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies. | Front Oncol | 2025 | https://conductscience.org/library/papers/41069341 | PubMed |
| 40913249 | Exacerbation of paclitaxel-induced neuropathic pain behaviors in breast tumor-bearing mice. | Mol Pain | 2025 | https://conductscience.org/library/papers/40913249 | PubMed |
| 40851994 | Hypoxia-driven angiogenesis in breast cancer mechanisms and therapeutic targets: a narrative review. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40851994 | PubMed |
| 40804731 | Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40804731 | PubMed |
| 40730501 | Bufalin Suppresses Triple-Negative Breast Cancer Stem Cell Growth by Inhibiting the Wnt/β-Catenin Signaling Pathway. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40730501 | PubMed |
| 40719975 | The effect of dendrosomal nanocurcumin on Wnt/β-catenin signaling pathway via PIWIL2 in MCF-7 breast cancer cells. | Med Oncol | 2025 | https://conductscience.org/library/papers/40719975 | PubMed |
| 40486584 | Oxygen deprivation in breast cancer: mechanisms, pathways, and implications. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40486584 | PubMed |
| 40285986 | NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40285986 | PubMed |
| 40093866 | ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/40093866 | PubMed |
| 39882028 | Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer. | Int J Breast Cancer | 2025 | https://conductscience.org/library/papers/39882028 | PubMed |
| 39461917 | MicroRNA-205-5p inhibits the growth and migration of breast cancer through targeting Wnt/β-catenin co-receptor LRP6 and interacting with lncRNAs. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/39461917 | PubMed |
| 39006318 | Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer. | Adv Ther (Weinh) | 2024 | https://conductscience.org/library/papers/39006318 | PubMed |
| 38999849 | Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial-Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature. | Nutrients | 2024 | https://conductscience.org/library/papers/38999849 | PubMed |
| 38292186 | The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | https://conductscience.org/library/papers/38292186 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| FZD1 | 8321 | PubTator's text mining | https://conductscience.org/library/genes/8321 | NCBI Gene |
| FZD7 | 8324 | PubTator's text mining | https://conductscience.org/library/genes/8324 | NCBI Gene |
| LRP6 | 4040 | PubTator's text mining | https://conductscience.org/library/genes/4040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21898546
GET https://conductscience.org/api/papers/v1/21898546/references?page=2